Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2009

View Archived Issues

Anti-cathepsin S monoclonal antibody developed by Fusion Antibodies for cancer immunotherapy

VaxInnate's recombinant hemagglutinin influenza vaccines safe and immunogenic in healthy adults

AS-703026, a novel allosteric inhibitor of MEK, displays potent preclinical antitumor activity

IT-101 regimens compared in patients with refractory solid tumors

LTX-109 shows low propensity for in vitro resistance development in S. aureus isolates

Copper/AAV-based gene therapy increases survival in model of Menkes disease / News in Context

Boston Scientific launches Taxus Element paclitaxel-eluting coronary stent

Solvay signs partnership agreement with Huya Bioscience for access to Chinese molecule portfolio

Amgen describes p38alpha MAPK modulators for the treatment of inflammation

Phase II data on Lu-AA-21004 in depression presented, product advances to phase III

Millennium Pharmaceuticals claims proteasome inhibitors for cancer treatment

Long-acting octreotide improves cystoid maculopathy in some patients

Post-hoc data show no role for gemfibrozil in atrial fibrillation in coronary heart disease subjects

Effects of lutein supplementation in age-related macular degeneration evaluated in the EMPOLS study

Pixantrone trial shows minimal cardiac effects despite doxorubicin treatment

Santhera's phase III IONIA Trial in Friedreich's ataxia misses primary endpoint

Argenta Discovery extends major drug discovery collaboration with Genentech

Enobia's ENB-0040 receives FDA fast track designation

IntelGenx and Circ Pharma to commence proof-of-concept study of CRES pravastatin

Sucampo initiates pivotal Japanese phase III lubiprostone trial in idiopathic constipation

Bionomics to initiate human clinical trial of anxiety drug BNC-210 in Australia

Medtronic and Lilly sign marketing collaboration to provide education on diabetes

Merck & Co. to launch Tredaptive/Cordaptive in international markets in 2009

Mitsubishi Tanabe Pharma obtains approval in Japan for additional indication for Valixa

Novel tyrosine kinase inhibitors for cancer treatment discovered by Janssen

Lilly advances second Alzheimer's candidate into late-stage clinical testing

European Commission approves Qutenza for peripheral neuropathic pain

FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...